Phase II evaluation and plasma pharmacokinetics of high-dose intravenous 6-thioguanine in patients with colorectal carcinoma
- 1 June 1982
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 8 (2) , 199-203
- https://doi.org/10.1007/bf00255484
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Reversed-phase high-performance liquid chromatography analysis of 6-thioguanine applicable to pharmacologic studies in humansJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- PHASE-I AND PRELIMINARY PHASE-II OBSERVATIONS OF HIGH-DOSE INTERMITTENT 6-THIOGUANINE1980
- Chemotherapy of colorectal carcinoma.1976
- Chemotherapy of gastrointestinal cancer.1976
- Phase II trials with procarbazine (NSC-77213), streptozotocin (NSC-85998), 6-THIOGUANINE (NSC-752), and CCNU (NSC-79037) in patients with metastatic cancer of the large bowel.1975
- Hematuria and Crystalluria after High-Dose 6-Mercaptopurine AdministrationNew England Journal of Medicine, 1972
- Pharmacology of 6-thioguanine in man.1971
- Experimental, clinical, and metabolic studies of thiopurines.1962